At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...
The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency partially depends ...
Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology ...
A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Lead program UKK-0018 for peanut allergy has received regulatory clearance in AU and NZ to begin clinical trials in 1H 2026Expands leadership with appointment of Grace Chen-Philips, M.D., as Chief ...
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
In a surprising discovery, University of New Mexico researchers have found that OTULIN – an enzyme that helps regulate the immune system – also drives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback